Skip to main content
. 2015 Jul 1;6(27):24320–24332. doi: 10.18632/oncotarget.4462

Figure 3E. Western blot demonstrating Inhibition of the phosphorylation of the ALK protein and other downstream signal molecules in the EML4-ALK CRC patient tumor derived cell line after inhibition by crizotinib or entrectinib.

Figure 3E